Visit our Re-post guidelines
The harms caused by human papillomavirus (HPV) vaccination can be complex, severe, and exceedingly difficult to treat. However, a promising new study shows there is hope for those whom conventional medicine has failed.
HPV vaccination is associated with a high rate of adverse events relative to other commonly administered vaccines. Indeed, the GreenMedInfo HPV vaccine database contains research indicating over two dozen diseases linked to either Merck’s Gardasil® or GlaxoSmithKline’s Cervavix® vaccines. Unfortunately, many vaccine injuries are both underreported and difficult to diagnose.
One such example is known as dysautonomic syndrome. This condition is characterized by the autonomic nervous system not working properly, and encompasses a group of diseases including orthostatic tachycardia syndrome, multiple system atrophy, autonomic failure, and autonomic neuropathy.
While syndromes like dysautonomia are notoriously difficult to treat, a new study published in the Israel Medical Association Journal indicates an exceedingly safe plant used for thousands of years as a medicine may have profound therapeutic value in the condition. Titled, “Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome after Human Papillomavirus Vaccination,” the new study sought to evaluate the short-term effect of cannabinoid-enriched hemp oil for relieving symptoms and improving the life quality (QOL) in young girls with adverse drug effects following human papillomavirus (HPV) vaccine.
The researchers reasoned that,
“Due to the absence of a safe and effective therapy for these girls who were living with their families and having to deal with difficult conditions (such as emotional instability, social problems as well as school obligations), and suspecting that an endogenous cannabinoid network imbalance might be responsible for some of the described symptoms, we selected a natural therapeutic approach based on CBD-enriched hemp oil over a 3 month period in our Italian cohort.”
The study design was described as follows:
"In this anecdotal, retrospective, "compassionate-use", observational, open-label study, 12 females (age 12-24 years) with severe somatoform and dysautonomic syndrome following HPV vaccination were given sublingual CBD-rich hemp oil drops, 25 mg/kg per day supplemented by 2-5 mg/ml CBD once a week until a maximum dose of 150 mg/ml CBD per day was reached over a 3 month period. Patients' quality of life was evaluated using the medical outcome short-form health survey questionnaire (SF-36)."
The results were reported as follows:
"Two patients dropped out due to iatrogenic adverse events and another two patients stopped the treatment early due to lack of any improvement. SF-36 showed significant benefits in the physical component score (P < 0.02), vitality (P < 0.03) and social role functioning (P < 0.02) after the treatment. The administration of hemp oil also significantly reduced body pain according to the SF-36 assessment. No significant differences from the start of treatment to several months post-treatment were detected in role limitations due to emotional reactions (P = 0.02)."
The researchers concluded:
"This study demonstrated the safety and tolerability of CBD-rich hemp oil and the primary efficacy endpoint. Randomized controlled trials are warranted to characterize the safety profile and efficacy of this compound."
This study reveals the potential value of cannabis sativa components in addressing adverse health effects caused by HPV vaccine. This is not at all surprising considering the panacea-like reputation of this ancient plant food-medicine, whose therapeutic properties may apply to a broad range of neurological disorders. For instance, GreenMedInfo contains a database of research on the potential preventive and therapeutic value of cannabinoids in over 250 different conditions. View the cannabis research here.
While this latest study's findings are promising, it should be emphasized that the best form of medicine is prevention. Obviously, HPV vaccine induced dysautonomia is not caused by a lack of cannabinoids. Clearly, if the HPV vaccine is the cause of autonomic nervous system dysregulation then the solution is avoidance of this vaccine altogether. But isn't the vaccine life-saving? Hasn't it been extensively tested for safety and efficacy through clinical trials before being approved? The asnwers to these questions may surprise you. For further background on HPV vaccines, and their unintended, adverse health effects, read the following articles: